Outcome with total therapy 3 (TT3) compared to total therapy 2 (TT2): Role of GEP70-defined high-risk disease with trisomy of 1q21 and activation of the proteasome gene PSMD4.
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. D. Shaughnessy, P. Qu, E. Tian, R. Edmondson, B. P. Nair, S. Waheed, Y. Alsayed, F. Van Rhee, J. Haessler, J. Crowley, B Barlogie
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2529112655